TRV-2026-3079Version 1 · Published

Saved · see the current record

Why this version exists

Certified into the record

The exact text we saved

This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.

TRUVACE RECORD VERSION
record: TRV-2026-3079
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-11-20T18:02:10.090830Z
status: published
lens: g_space
sector: health
headline: Multimodal multitask deep learning for predicting tertiary lymphoid structures and peritoneal recurrence in gastric cancer: a multicentre development, validation, and testing study
dek: Peritoneal recurrence remains a common and fatal complication following curative gastric cancer surgery. Tertiary lymphoid structures are crucial indicators of immune response in cancer, and their maturation is associated with better prognosis and therapy outcomes. Evaluation of these structures could improve patient stratification for treatment of cancer but is hindered by the invasive and biased nature of histological methods. This study aimed to explore a non-invasive radiological method of assessment in pati…
gain_title: In a retrospective study of eight Chinese gastric cancer cohorts, the CTransNet model split patients by risk: in the training cohort, 5-year peritoneal recurrence was 66.69% with low scores versus 26.28% with high scores.
problem_title: (none)
trace_subject: (none)
gain_reading: In a retrospective study of eight Chinese gastric cancer cohorts, the CTransNet model split patients by risk: in the training cohort, 5-year peritoneal recurrence was 66.69% with low scores versus 26.28% with high scores.
gain_evidence: objective response rates were higher for patients with high predicted scores than for those with low predicted scores (54·5% vs 5·6%
problem_reading: (none)
problem_evidence: (none)
quick_read: Researchers built CTransNet, a model combining a convolutional neural network (ResNet50) and a Transformer, to estimate from radiological imaging whether gastric cancer patients have tertiary lymphoid structures, immune formations linked to prognosis, and how mature they are. It also predicts peritoneal recurrence-free survival. In the training cohort, the area under the curve was 0.910 for absent structures (TLS0), 0.925 for primary follicle-like structures (TLS1) and 0.953 for mature structures (TLS2).

Patients with low model scores had much higher 5-year peritoneal recurrence rates than those with high scores: 66.69% versus 26.28% in the training cohort. The score remained an independent predictor of peritoneal recurrence-free, disease-free and overall survival in multivariate analysis. Tissue-based assessment of these structures is invasive and biased, which is the gap a scan-based method would fill.

The score also tracked treatment response. Among stage II or III patients, adjuvant chemotherapy was linked to better disease-free and overall survival in those with low scores but not those with high scores. In two immunotherapy cohorts, objective response rates were 54.5% versus 5.6% and 53.1% versus 9.7% for high versus low scores. The authors describe the model as a potential tool for personalised care, not one proven in clinical use.
limitation: The model was developed and tested on retrospective data from Chinese hospitals only, and its concordance index for predicting peritoneal recurrence-free survival was a modest 0.654 in the training cohort.
tag: Evidence-backed gain
key_points: CTransNet pairs ResNet50 with a Transformer and predicts tertiary lymphoid structure status (TLS0, TLS1, TLS2) and peritoneal recurrence-free survival from imaging. | Training-cohort AUCs for classifying structure status were 0.910 (TLS0), 0.925 (TLS1) and 0.953 (TLS2). | Five-year peritoneal recurrence in the training cohort was 66.69% for low-score patients versus 26.28% for high-score patients (p<0.0001). | Risk stratification by model score was an independent predictor of peritoneal recurrence-free, disease-free and overall survival. | Among two immunotherapy cohorts treated with anti-PD-1 or anti-PD-L1 drugs, response rates were 54.5% vs 5.6% and 53.1% vs 9.7% for high vs low scores.
rundown: The study used retrospective data from patients treated at Nanfang Hospital, Sun Yat-sen University Cancer Center, Yunnan Cancer Hospital and Guangdong Provincial Hospital of Chinese Medicine. The eight cohorts comprised one training cohort, two internal validation cohorts, three external validation cohorts and two independent immunotherapy cohorts. Patients were recruited between 1 January 2005 and 28 February 2022.

Structure status was established with haematoxylin-eosin and immunohistochemistry staining, and peritoneal recurrence was assessed by imaging, clinical signs or reoperation. Patients were split into high and low risk groups using the median predicted score from the training cohort, a cut-off then applied to the validation cohorts. Survival was analysed with Kaplan-Meier methods and Cox models.

For predicting peritoneal recurrence-free survival, the model reached a concordance index of 0.654 in the training cohort. In stage II and III patients, low scores identified those in whom adjuvant chemotherapy was associated with better survival, while high-score patients showed no such association. The authors suggest this could help clinicians optimise treatment strategies.
sources:
- peer_reviewed | The Lancet Digital Health | https://doi.org/10.1016/j.landig.2026.101075 | 2026-11-19
prev: 0000000000000000000000000000000000000000000000000000000000000000
SHA-256 hash
5b7c7d8849d6be2a061956685e32ac4d1d4cd8b2aa2781abb3081061bd838e45
Previous version’s hash
0000000000000000000000000000000000000000000000000000000000000000
Check this record hasn’t been altered
How to check it yourself, without trusting this page

Download any version from /api/record/TRV-2026-3079 and hash its canonical field yourself, for example with shasum -a 256. You should get its content_hash. Each version’s text also ends with prev:and the hash of the version before it (version 1 points to 64 zeros). If anyone had changed a single character of any version after it was saved, those hashes wouldn’t line up.